SCAI: Iliac stents gain MOBILITY in treatment of PAD 
Health Imaging
LAS VEGAS?When treating a real-world sample of patients for intermittent claudication or critical limb ischemia, two off-label iliac artery stents showed a statistically significant performance goal for low major adverse event rates, according to the ...

and more » 

Stenting Safe in Aorto-Iliac Disease 
MedPage Today
Jaff noted that iliac artery stent trials generally don't include patients with intermittent claudication or critical limb ischemia. MOBILITY, however, did not shy away from these patients or those with very complex lesions. "Almost 100% of patients ...

and more » 

Pluristem stem cells save girl's life 
Chicago Tribune
Pluristem recently received US FDA clearance to begin a Phase II clinical trial using the company's proprietary PLX-PAD cell product candidate intramuscularly for the treatment of Intermittent Claudication (IC), a subset of peripheral artery disease ...

and more » 

Spinal Stenosis - Is That What The Symptoms Say? 
About.com Back and Neck Pain Site
Anyway, the reviewers found that age (greater than 70 years), pain with walking, neurogenic claudication, bilateral butt or leg pain, unexpected urinary problems, no pain when sitting and pain relief when bending forward all correlated with a diagnosis ...

 

Pluristem stem cell therapy saves a patient, shares jump 
Chicago Tribune
Last month, the US health regulators gave a go ahead to the company to start a mid-stage trial of the therapy for treating Intermittent Claudication -- a subset of peripheral artery disease. Pluristem shares, which have gained 5 percent since receiving ...
Compassionate Use of Pluristem's PLX Cells Saves the Life of a Child After ... MarketWatch (press release)

all 14 news articles » 

Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of ... 
MarketWatch (press release)
The MOBILITY trial was designed to test the effectiveness of a self-expanding stent system and a balloon-expandable stent system in patients with intermittent claudication (IC) or critical limb ischemia (CLI) with even the most complex lesions.

and more » 

Pacific Therapeutics Ltd. Progress of Clinical Development 
TheNewswire.ca (press release)
The company's lead drug candidate PTL-202 is a combination of Pentoxifylline (a FDA approved drug used for treating intermittent claudication) and N-Acetyl-Cysteine (NAC) an amino acid and an extremely potent and important antioxidant.

 

Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of ... 
Sacramento Bee
The MOBILITY trial was designed to test the effectiveness of a self-expanding stent system and a balloon-expandable stent system in patients with intermittent claudication (IC) or critical limb ischemia (CLI) with even the most complex lesions.

and more » 

Cardiovascular Systems Reports Fiscal 2012 Third-Quarter Financial Results 
MarketWatch (press release)
Of these patients, 64.9 percent had claudication and 35.1 percent had critical limb ischemia. The mean Diamondback 360 deg run time was only 55 seconds. Low-pressure adjunctive angioplasty was performed in all cases. The average pre-procedure vessel ...

and more » 

Cytokinetics Announces Presentation of Preclinical Data Regarding CK-2017357 ... 
MarketWatch (press release)
In addition, CK-2017357 has shown pharmacological activity in healthy volunteers, in patients with ALS, and in patients with peripheral artery disease and claudication. The clinical effects of muscle wasting, fatigue and loss of mobility can range from ...

and more »